US stock futures rose as investors anticipated President Trump's deadline for Iran regarding the Strait of Hormuz. UnitedHealth Group shares jumped over 6% after a favorable Medicare payment update, while Silo Pharma surged 45% following a key patent development. Despite geopolitical tensions and rising oil prices impacting Phillips 66 negatively, analysts remain optimistic about the US market's long-term growth, expecting strong corporate earnings to support gains. Investors await upcoming economic data and Fed speeches for further market direction.
Piper Sandler raised its price target for UnitedHealth Group to $475, suggesting a 13.3% upside from its current price of $419.23. The company, the largest U.S. health insurer, has consistently beaten earnings estimates, with its latest EPS of $7.23 ...
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
Elevance Health and UnitedHealth Group, two of the largest U.S. health insurers, are set to report their second-quarter earnings this week. Investors and analysts are watching closely to see if these companies have maintained control over rising medi...
